1. Home
  2. CORT vs REXR Comparison

CORT vs REXR Comparison

Compare CORT & REXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • REXR
  • Stock Information
  • Founded
  • CORT 1998
  • REXR 2013
  • Country
  • CORT United States
  • REXR United States
  • Employees
  • CORT N/A
  • REXR N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • REXR Real Estate Investment Trusts
  • Sector
  • CORT Health Care
  • REXR Real Estate
  • Exchange
  • CORT Nasdaq
  • REXR Nasdaq
  • Market Cap
  • CORT 7.5B
  • REXR 8.6B
  • IPO Year
  • CORT N/A
  • REXR 2013
  • Fundamental
  • Price
  • CORT $69.36
  • REXR $37.28
  • Analyst Decision
  • CORT Strong Buy
  • REXR Hold
  • Analyst Count
  • CORT 4
  • REXR 9
  • Target Price
  • CORT $142.00
  • REXR $39.44
  • AVG Volume (30 Days)
  • CORT 840.5K
  • REXR 3.4M
  • Earning Date
  • CORT 08-05-2025
  • REXR 07-16-2025
  • Dividend Yield
  • CORT N/A
  • REXR 4.58%
  • EPS Growth
  • CORT 8.36
  • REXR 11.21
  • EPS
  • CORT 1.14
  • REXR 1.35
  • Revenue
  • CORT $685,446,000.00
  • REXR $986,532,000.00
  • Revenue This Year
  • CORT $35.85
  • REXR $10.10
  • Revenue Next Year
  • CORT $35.22
  • REXR $7.08
  • P/E Ratio
  • CORT $59.71
  • REXR $27.92
  • Revenue Growth
  • CORT 30.93
  • REXR 13.72
  • 52 Week Low
  • CORT $32.33
  • REXR $29.68
  • 52 Week High
  • CORT $117.33
  • REXR $52.61
  • Technical
  • Relative Strength Index (RSI)
  • CORT 42.54
  • REXR 56.76
  • Support Level
  • CORT $67.44
  • REXR $35.12
  • Resistance Level
  • CORT $70.44
  • REXR $37.94
  • Average True Range (ATR)
  • CORT 2.02
  • REXR 0.97
  • MACD
  • CORT -0.30
  • REXR 0.05
  • Stochastic Oscillator
  • CORT 11.99
  • REXR 81.54

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About REXR Rexford Industrial Realty Inc.

Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.

Share on Social Networks: